126 results on '"Rieder, Florian"'
Search Results
2. HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis
3. MFGE8 links absorption of dietary fatty acids with catabolism of enterocyte lipid stores through HNF4γ-dependent transcription of CES enzymes
4. Ozanimod as a novel oral small molecule therapy for the treatment of Crohn's disease: The YELLOWSTONE clinical trial program
5. Test Characteristics of Cross-sectional Imaging and Concordance With Endoscopy in Postoperative Crohn’s Disease
6. The Future of Precision Medicine to Predict Outcomes and Control Tissue Remodeling in Inflammatory Bowel Disease
7. Biomarkers for the Prediction and Diagnosis of Fibrostenosing Crohn’s Disease: A Systematic Review
8. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
9. Biologic agents and small molecules – mechanism of action
10. Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor
11. Elafin Reverses Intestinal Fibrosis by Inhibiting Cathepsin S-Mediated Protease-Activated Receptor 2
12. Novel Functions of the Septin Cytoskeleton: Shaping Up Tissue Inflammation and Fibrosis
13. Quantitative Analysis of Patellar Tendon After Total Knee Arthroplasty Using Echo Intensity: A Nonrandomized Controlled Trial of Alpine Skiing
14. Efficacy of Endoscopic Dilation of Gastroduodenal Crohn’s Disease Strictures: A Systematic Review and Meta-Analysis of Individual Patient Data
15. Thickened submucosal adipose tissue layer during endoscopic submucosal dissection of inflammatory bowel disease dysplasia
16. Pathogenesis of fibrostenosing Crohn's disease
17. Treatments for Crohn’s Disease–Associated Bowel Damage: A Systematic Review
18. The emerging role of histologic disease activity assessment in ulcerative colitis
19. Sa1842 INFLAMMATORY BOWEL DISEASE ACTIVITY IS ASSOCIATED WITH LARGE JOINT PERIPHERAL SPONDYLOARTHRITIS, BUT NOT WITH THE NUMBER OF INVOLVED JOINTS
20. Mo1784 HIGH-RESOLUTION IMPEDANCE PLANIMETRY CHARACTERIZES THE MECHANICAL FEATURES OF CROHN'S DISEASE STRICTURES – IMPLICATIONS FOR PATIENT STRATIFICATION
21. Su1740 TOPICAL SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR 1 MODULATION REGULATES GUT ANGIOGENESIS IN INFLAMMATORY BOWEL DISEASES
22. Sa1267 ESOPHAGEAL LUMINAL DIAMETER IS ASSOCIATED WITH DYSPHAGIA IN EOSINOPHILIC ESOPHAGITIS: IMPLICATIONS FOR ENDOSCOPIC DILATION THERAPY
23. 1142 INTEGRIN INHIBITION REDUCES PROFIBROTIC RESPONSES IN CROHN'S DISEASE (CD) HUMAN INTESTINAL MYOFIBROBLASTS IN VITRO AND AMELIORATES EXPERIMENTAL INTESTINAL FIBROSIS IN VIVO - A POTENTIAL NOVEL APPROACH TO CD STRICTURE THERAPY
24. Sa1881 MICROBIAL TRIMETHYLAMINE EXERTS PROFIBROTIC PROPERTIES IN IBD - IMPLICATIONS FOR NOVEL ANTI-FIBROTIC THERAPIES
25. Sa1199 CONDENSINS ARE UPREGULATED IN CROHN'S DISEASE PATIENT ILEAL EPITHELIAL CELLS AND PROMOTE INTESTINAL PERMEABILITY
26. 963 THE BREATH METABOLOME SIGNATURE IS LINKED WITH DIAGNOSIS OF EOSINOPHILIC ESOPHAGITIS: PILOT STUDY ASSESSING EXHALED VOLATILE ORGANIC COMPOUNDS
27. 760 TRANSGLUTAMINASE 2 IS ELEVATED IN CROHN'S DISEASE ASSOCIATED STRICTURES AND EXERTS PROFIBROTIC ACTIVITIES IN MYOFIBROBLASTS AND EXPERIMENTAL INTESTINAL FIBROSIS
28. Tu1740 LOCAL BIOACTIVATION AND EFFICACY OF PALI-2108: A PROMISING PDE4 INHIBITOR PRODRUG FOR ULCERATIVE COLITIS TREATMENT
29. 173 DUAL ACTIVATION OF GCGR/GLP1R SIGNALING AMELIORATES INTESTINAL FIBROSIS VIA METABOLIC REGULATION OF HISTONE H3K9 LACTYLATION IN EPITHELIAL CELLS
30. Mo1763 POSTOPERATIVE RECURRENCE IN INFLAMMATORY BOWEL DISEASE ASSOCIATED PERMANENT END ILEOSTOMY: A SYSTEMATIC REVIEW
31. Su1770 EFFECT OF RISANKIZUMAB ON EARLY SYMPTOMS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: A POST-HOC ANALYSIS OF THE INSPIRE INDUCTION STUDY
32. 1095 EXHALED BREATH ANALYSIS OF VOLATILE ORGANIC COMPOUNDS IS ASSOCIATED WITH LUMINAL DISEASE ACTIVITY IN PATIENTS WITH ULCERATIVE COLITIS
33. Inflammation-Induced Endothelial-to-Mesenchymal Transition: A Novel Mechanism of Intestinal Fibrosis
34. Single-cell isolation from full-thickness human intestinal tissue resections for single-cell RNA sequencing
35. Su1694 LONG RECTAL CUFF SYNDROME AFTER ILEOANAL POUCH FOR INFLAMMATORY BOWEL DISEASE
36. Tu1977 VALIDATION OF RADIOMICS FEATURES ON MR ENTEROGRAPHY CHARACTERIZING INFLAMMATION AND FIBROSIS IN STRICUTRING CROHN'S DISEASE
37. Tu1976 CT ENTEROGRAPHY RADIOMICS FEATURES CHARACTERIZE INFLAMMATION AND FIBROSIS IN STRICTURING CROHN'S DISEASE – A DERIVATION AND VALIDATION STUDY
38. Tu1787 VEDOLIZUMAB AS A MEDICAL THERAPY FOR SYMPTOMATIC STRICTURING SMALL BOWEL CROHN'S DISEASE - RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT STUDY
39. Tu1781 EFFICACY OF USTEKINUMAB IN THE TREATMENT OF FIBROSTENOTIC CROHN'S DISEASE AS ASSESSED BY INTESTINAL ULTRASOUND
40. Tu1718 A PHASE 1B STUDY TO EVALUATE SAFETY, TOLERABILITY, PHARMACOKINETICS AND CLINICAL EFFICACY OF THE NUCLEOTIDEBINDING OLIGOMERIZATION DOMAIN, LEUCINE RICH REPEAT CONTAINING X1 (NLRX1) AGONIST NX-13 IN ULCERATIVE COLITIS
41. Tu1710 ADDITIONAL RISANKIZUMAB TREATMENT IS EFFECTIVE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE WHO DID NOT ACHIEVE CDAI CLINICAL RESPONSE WITH THE INITIAL 12-WEEK INDUCTION TREATMENT: RESULTS FROM THE ADVANCE, MOTIVATE, AND FORTIFY STUDIES
42. Tu1256 USTEKINUMAB FOR THE TREATMENT OF SYMPTOMATIC SMALL BOWEL STRICTURING CROHN'S DISEASE - RESULTS FROM AN INTERNATIONAL MULTICENTER COHORT STUDY
43. Tu1249 CROHN'S DISEASE INTESTINAL MUSCLE CELL DERIVED FIBRONECTIN PROMOTES PROLIFERATION OF INTESTINAL MUSCULARIS PROPRIA MUSCLE CELLS – A NOVEL LINK BETWEEN MUSCLE FIBROSIS AND PROLIFERATION IN STRICTURING CROHN'S DISEASE
44. Tu1246 CROHN'S DISEASE STRICTURE MATRISOME ANALYSIS REVEALS THE ANTI-FIBROTIC ACTIVITY OF MILK-FAT GLOBULE-EPIDERMAL GROWTH FACTOR 8 (MFGE8)
45. Mo1735 EARLY HISTO-ENDOSCOPIC RESPONSE AT WEEK 12 PREDICTS CLINICAL OUTCOMES AT WEEK 52 WITH MIRIKIZUMAB IN ULCERATIVE COLITIS LUCENT TRIALS
46. Mo1726 INTESTINAL ULTRASOUND OF FIBROSTENOTIC CROHN'S DISEASE CORRELATES WITH HISTOLOGY OF SURGICALLY RESECTED STRICTURES
47. Mo1039 CREATION OF A SUBSPECIALTY LEARNING COMMUNITY FOR ADVANCED INFLAMMATORY BOWEL DISEASE FELLOWS ANCHORED IN COMPETENCY BASED EDUCATION: THE MILESTONE INITIATIVE
48. 951 CREEPING FAT-DERIVED LONG CHAIN FREE FATTY ACIDS DRIVE INTESTINAL MUSCULARIS PROPRIA MUSCLE CELL PROLIFERATION VIA LIPID METABOLISM AND CARNITINE PALMITOYLTRANSFERASE 1 (CPT-1) - A RELEVANT MECHANISM FOR STRICTURING CROHN'S DISEASE
49. 947 EFFICACY AND SAFETY OF UPADACITINIB FOR THE TREATMENT OF FISTULAS AND FISSURES IN PATIENTS WITH CROHN'S DISEASE
50. Not Hard to Swallow—Understanding Endothelial-Fibroblast Crosstalk in Eosinophilic Esophagitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.